BREZTRI 4.8 ug/1

BREZTRI 4.8 ug/1 is a combination inhaler containing budesonide, glycopyrrolate, and formoterol fumarate. It is used for respiratory conditions like COPD and asthma. This metered aerosol inhaler is designed for easy inhalation.

BREZTRI 4.8 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The combination of budesonide, glycopyrrolate, and formoterol fumarate works to reduce inflammation and improve breathing. This inhaler is often prescribed to manage symptoms such as wheezing, shortness of breath, and coughing. It is important to consult a healthcare provider to determine if this medication is suitable for your specific condition.

Common effects of BREZTRI 4.8 ug/1 may include throat irritation, hoarseness, and dry mouth. Some users may experience headaches or tremors. These effects are generally mild and temporary. If you experience severe or persistent side effects, it is advisable to seek medical attention.

BREZTRI 4.8 ug/1 should be used as directed by a healthcare provider. It is important to follow the prescribed dosage and administration instructions. This inhaler should be stored at room temperature and kept away from moisture and heat. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

BREZTRI 4.8 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to discuss all your current medications with your healthcare provider to avoid potential interactions. Additionally, avoid using this inhaler with other long-acting beta-agonists unless directed by a healthcare professional.